Kala-azar in childhood: A survey of clinical and laboratory findings and prognosis in 44 childhood cases
Hicsonmez G, Ozsoylu S. Kala-azar in childhood: A survey of clinical and laboratory findings and prognosis in 44 childhood cases. Clin Pediatr (Phila) 1972; 11: 465-467.
Kalaazar in a one-year-old Swedish child. Diagnostic difficulties because of active hemophagocytosis
Granert C, Elinder G, Ost A, Henter JI. Kalaazar in a one-year-old Swedish child. Diagnostic difficulties because of active hemophagocytosis. Acta Pediatr 1993; 82: 794-796.
Visceral leishmaniasis in HIV infected patients: Treatment with high dose liposomal amphotericin B (AmBisome)
Russo R, Nigro LC, Minniti S, Montineri A, Gradoni L, Caldeira L. Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome). J Infect 1996; 32: 133-137.
Hemophagocytic syndrome: A rare life-threatening complication of visceral leishmaniasis in a young boy
Tunc B, Ayata A. Hemophagocytic syndrome: a rare life-threatening complication of visceral leishmaniasis in a young boy. Pediatr Hematol Oncol 2001; 18: 531-536.
Hemophagocytic syndrome: A misleading complication of visceral leishmaniasis in children - A series of twelve cases
Gegnaire MH, Galambrun C, Stephan JL. hemophagocytic syndrome: A misleading complication of visceral leishmaniasis in children - A series of twelve cases. Pediatrics 2000; 106: e58.
US Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis
US Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin Infect Dis 1999; 28:42-48.